| Protective immunity to DENV2 after immunization with a recombinant NS1 protein using a genetically detoxified heat-labile toxin as an adjuvant JH Amorim, MO Diniz, FAMO Cariri, JF Rodrigues, RSP Bizerra, ... Vaccine 30 (5), 837-845, 2012 | 101 | 2012 |
| Bacillus subtilis Spores as Vaccine Adjuvants: Further Insights into the Mechanisms of Action RD De Souza, MT Batista, WB Luiz, RCM Cavalcante, JH Amorim, ... PLoS One 9 (1), e87454, 2014 | 62 | 2014 |
| Antibodies are not required to a protective immune response against dengue virus elicited in a mouse encephalitis model JH Amorim, RP dos Santos Alves, R Bizerra, SA Pereira, LR Pereira, ... Virology 487, 41-49, 2016 | 31 | 2016 |
| A genetic and pathologic study of a DENV2 clinical isolate capable of inducing encephalitis and hematological disturbances in immunocompetent mice JH Amorim, RS Pereira Bizerra, RP dos Santos Alves, ... Public Library of Science 7 (9), e44984, 2012 | 26 | 2012 |
| Dengue virus models based on mice as experimental hosts JH Amorim, R Bizerra, RP dos Santos Alves, DL Nascimento Fabris, ... Future Virology 10 (7), 835-844, 2015 | 3 | 2015 |
| Desenvolvimento de uma vacina de subunidade contra o sorotipo 2 do vírus dengue baseada no domínio helicase da proteína NS3. RSP Bizerra Universidade de São Paulo, 2014 | 2 | 2014 |
| Protective immunity to type 2 dengue virus after immunization with a recombinant non-structural 1 (NS1) protein and a nontoxic heat-labile toxin (LTG33D) as adjuvant JH Amorim, MO Diniz, FAMO Cariri, JF Rodrigues, RS Bizerra, AMB Alves, ... | | 2011 |
| Functional and immunological features of a recombinant dengue virus nonstructural protein 3 (NS3) helicase domain RSP Bizerra, JH Amorim, A Balan, A Silva, RP dos Santos Alves, ... | | |
